New! View global litigation for patent families

DE69113273T2 - Zellnekrosnachweis durch prüfung von spektrin und seine abbauprodukte. - Google Patents

Zellnekrosnachweis durch prüfung von spektrin und seine abbauprodukte.

Info

Publication number
DE69113273T2
DE69113273T2 DE1991613273 DE69113273T DE69113273T2 DE 69113273 T2 DE69113273 T2 DE 69113273T2 DE 1991613273 DE1991613273 DE 1991613273 DE 69113273 T DE69113273 T DE 69113273T DE 69113273 T2 DE69113273 T2 DE 69113273T2
Authority
DE
Grant status
Grant
Patent type
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE1991613273
Other languages
English (en)
Other versions
DE69113273D1 (de )
Inventor
Gary Lynch
David Eveleth
Peter Seubert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/558Immunoassay; Biospecific binding assay using diffusion or migration of antigen or antibody
    • G01N33/561Immunoelectrophoresis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
DE1991613273 1988-09-02 1991-07-11 Zellnekrosnachweis durch prüfung von spektrin und seine abbauprodukte. Expired - Lifetime DE69113273T2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US07558700 US5118606A (en) 1988-09-02 1990-07-26 Methods for detecting cellular pathology by assaying spectrin and spectrin breakdown products
PCT/US1991/004910 WO1992001935A1 (en) 1990-07-26 1991-07-11 Cell necrosis detection through assays for spectrin and breakdown products thereof

Publications (1)

Publication Number Publication Date
DE69113273T2 true DE69113273T2 (de) 1996-05-15

Family

ID=24230602

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1991613273 Expired - Fee Related DE69113273D1 (de) 1988-09-02 1991-07-11 Zellnekrosnachweis durch prüfung von spektrin und seine abbauprodukte.
DE1991613273 Expired - Lifetime DE69113273T2 (de) 1988-09-02 1991-07-11 Zellnekrosnachweis durch prüfung von spektrin und seine abbauprodukte.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE1991613273 Expired - Fee Related DE69113273D1 (de) 1988-09-02 1991-07-11 Zellnekrosnachweis durch prüfung von spektrin und seine abbauprodukte.

Country Status (8)

Country Link
US (1) US5118606A (de)
EP (1) EP0540591B1 (de)
JP (2) JP2824150B2 (de)
CA (1) CA2088050A1 (de)
DE (2) DE69113273D1 (de)
DK (1) DK0540591T3 (de)
ES (1) ES2077863T3 (de)
WO (1) WO1992001935A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444042A (en) * 1990-12-28 1995-08-22 Cortex Pharmaceuticals Method of treatment of neurodegeneration with calpain inhibitors
US5536639A (en) * 1994-03-25 1996-07-16 Cephalon, Inc. Methods for detecting calpain activation by detection of calpain activated spectrin breakdown products
CA2188816C (en) * 1996-04-23 2009-09-22 Takeda Chemical Industries, Ltd. Composition containing .alpha.-fodrin or .alpha.- fodrin fragment protein
US6011991A (en) * 1998-12-07 2000-01-04 Technology Patents, Llc Communication system and method including brain wave analysis and/or use of brain activity
CA2498614C (en) * 2002-09-11 2013-04-16 University Of Florida Analyzing nerve cell damage
ES2367311T3 (es) * 2004-04-15 2011-11-02 Banyan Biomarkers Productos de degradación proteolítica de map-2 como biomarcadores de diagnóstico para las lesiones neurales.
ES2482142T3 (es) * 2004-04-15 2014-08-01 University Of Florida Research Foundation, Inc. Proteínas neurales como biomarcadores para lesiones del sistema nervioso y otros trastornos neurales
US8492107B2 (en) * 2004-04-15 2013-07-23 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
WO2008097618A1 (en) * 2007-02-06 2008-08-14 University Of Florida Research Foundation, Inc. Synaptotagmin and collapsin response mediator protein as biomarkers for traumatic brain injury
WO2009026660A1 (en) 2007-08-30 2009-03-05 Walter And Eliza Hall Institute Of Medical Research Dendritic cell marker and uses thereof
CA2755983A1 (en) * 2009-03-23 2010-09-30 The Walter And Eliza Hall Institute Of Medical Research Compounds and methods for modulating an immune response
DE112009005237T5 (de) * 2009-09-18 2012-09-06 The Regents Of The University Of California Verfahren zum nachweisen von autodigestion
US20140087401A1 (en) * 2011-06-07 2014-03-27 Alexander Oliver Vortmeyer Biomarkers for Assessment of the Molecular Quality in Biospecimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2566327B2 (ja) * 1988-09-02 1996-12-25 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 細胞の病的変化を検出する方法

Also Published As

Publication number Publication date Type
JP2824150B2 (ja) 1998-11-11 grant
EP0540591A1 (de) 1993-05-12 application
ES2077863T3 (es) 1995-12-01 grant
US5118606A (en) 1992-06-02 grant
DE69113273D1 (de) 1995-10-26 grant
DK0540591T3 (da) 1996-02-05 grant
CA2088050A1 (en) 1992-01-27 application
JPH05508919A (de) 1993-12-09 application
JPH1130615A (ja) 1999-02-02 application
EP0540591B1 (de) 1995-09-20 grant
WO1992001935A1 (en) 1992-02-06 application

Similar Documents

Publication Publication Date Title
DE69019419T2 (de) Testscheiben.
DE69103226T2 (de) Zahnstangenritzelanordnung.
DE69121101T2 (de) Vibrator und seine Anwendung
DE69303010T2 (de) Prüfung von verpackungen
DE69021753T2 (de) Doppel- und Simultanprüfung.
DE69007482T2 (de) Nachweis von schimmeln.
DE69612973T2 (de) Verbesserung an der behandlung von proben
DE9311859U1 (de) Eierfrischhaltedose
DE9318346U1 (de) Speisenthermometer
DE69205318T2 (de) Selbsttätige Probenentnahme von Schüttgütern.
DE68920807T2 (de) Klebeband und seine Verwendung.
DE69104405T2 (de) Bleichmittelkatalysatoren und diese enthaltende Zusammensetzungen.
DE69405051T2 (de) Decantierzentrifuge zur Behandlung von nuklearen Produkten
DE68910870T2 (de) Frequenzganganalyse.
DE69127429T2 (de) Insektizid- und synergistische Mitizidezusammensetzungen
DE69009717D1 (de) Heteroaryl-3-oxo-propan-nitril-derivat verwendbar in erregung von myelopoiesis.
DE69017114D1 (de) Zerlegbares Metallgerüst.
FI921380A0 (fi) Kombination av foer tungt bruk avsedda radialdaeck foer avnvaendning under vintersaesong.
DE69024934D1 (de) Einbruch sicherungsvorrichtung
DE8025289U1 (de) Versand- und Vorratbehaelter
FI901366A0 (fi) Anordning foer tillvaratagande av lyftkraft i vaetska.
FI901352A0 (fi) Anordning foer slaecking av brytljusbaogen i lastbrytare.
FI900688A (fi) Anordning foer luftning av liggunderlag i sjuksaeng.
FI900627A0 (fi) 2,3,23-trihydroxiurs-12-en och dess derivat, foerfarande foer deras framstaellning och deras anvaendning.
DE69010756D1 (de) Granulatformulierung von Thiolcarbamat.